EventHumanResearch and development

PRIME is a scheme run by the European Medicines Agency (EMA) to enhance support for the development of medicines that target an unmet medical need. This voluntary scheme is based on enhanced interaction and early dialogue with developers of promising medicines, to optimise development plans and speed up evaluation so these medicines can reach...

HumanEarly accessRegulatory and procedural guidanceResearch and development

Massive amounts of data are generated on a daily basis that could potentially be harnessed to support medicines regulation. The European Medicines Agency (EMA) and Heads of Medicines Agencies (HMA) set up a joint task force to describe the big data landscape from a regulatory perspective and identify practical steps for the European medicines...

HumanVeterinaryCorporateData on medicinesInnovationResearch and development

The European Medicines Agency can give scientific advice to companies on the appropriate tests and studies in the development of veterinary medicines. This is designed to facilitate the development and availability of high-quality, effective and acceptably safe medicines.

VeterinaryRegulatory and procedural guidanceResearch and developmentScientific advice